Project
averaged GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for HIVEP1
Z-value: 1.97
Motif logo
Transcription factors associated with HIVEP1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
HIVEP1
|
ENSG00000095951.12 | HIVEP zinc finger 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| HIVEP1 | hg19_v2_chr6_+_12012536_12012571 | 0.06 | 3.5e-01 | Click! |
Activity profile of HIVEP1 motif
Sorted Z-values of HIVEP1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr6_+_32605195 | 47.63 |
ENST00000374949.2
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
| chr6_+_32709119 | 34.13 |
ENST00000374940.3
|
HLA-DQA2
|
major histocompatibility complex, class II, DQ alpha 2 |
| chr22_+_22930626 | 31.15 |
ENST00000390302.2
|
IGLV2-33
|
immunoglobulin lambda variable 2-33 (non-functional) |
| chr6_+_32407619 | 29.00 |
ENST00000395388.2
ENST00000374982.5 |
HLA-DRA
|
major histocompatibility complex, class II, DR alpha |
| chr14_-_106322288 | 26.02 |
ENST00000390559.2
|
IGHM
|
immunoglobulin heavy constant mu |
| chr6_+_32605134 | 25.50 |
ENST00000343139.5
ENST00000395363.1 ENST00000496318.1 |
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
| chr17_+_40440481 | 24.75 |
ENST00000590726.2
ENST00000452307.2 ENST00000444283.1 ENST00000588868.1 |
STAT5A
|
signal transducer and activator of transcription 5A |
| chr5_-_149792295 | 24.56 |
ENST00000518797.1
ENST00000524315.1 ENST00000009530.7 ENST00000377795.3 |
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain |
| chr6_+_29691198 | 24.50 |
ENST00000440587.2
ENST00000434407.2 |
HLA-F
|
major histocompatibility complex, class I, F |
| chr14_-_35873856 | 23.89 |
ENST00000553342.1
ENST00000216797.5 ENST00000557140.1 |
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
| chr6_-_31324943 | 23.69 |
ENST00000412585.2
ENST00000434333.1 |
HLA-B
|
major histocompatibility complex, class I, B |
| chr6_+_31554962 | 23.53 |
ENST00000376092.3
ENST00000376086.3 ENST00000303757.8 ENST00000376093.2 ENST00000376102.3 |
LST1
|
leukocyte specific transcript 1 |
| chr6_+_29691056 | 23.33 |
ENST00000414333.1
ENST00000334668.4 ENST00000259951.7 |
HLA-F
|
major histocompatibility complex, class I, F |
| chr6_-_31239846 | 22.61 |
ENST00000415537.1
ENST00000376228.5 ENST00000383329.3 |
HLA-C
|
major histocompatibility complex, class I, C |
| chr7_-_150497406 | 21.65 |
ENST00000492607.1
ENST00000326442.5 ENST00000450753.2 |
TMEM176B
|
transmembrane protein 176B |
| chr12_-_9913489 | 21.57 |
ENST00000228434.3
ENST00000536709.1 |
CD69
|
CD69 molecule |
| chr6_-_32908792 | 21.03 |
ENST00000418107.2
|
HLA-DMB
|
major histocompatibility complex, class II, DM beta |
| chr6_+_31555045 | 21.00 |
ENST00000396101.3
ENST00000490742.1 |
LST1
|
leukocyte specific transcript 1 |
| chr14_-_107049312 | 20.64 |
ENST00000390627.2
|
IGHV3-53
|
immunoglobulin heavy variable 3-53 |
| chr22_-_37640277 | 20.34 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
| chr6_+_29910301 | 19.58 |
ENST00000376809.5
ENST00000376802.2 |
HLA-A
|
major histocompatibility complex, class I, A |
| chr13_-_46756351 | 19.11 |
ENST00000323076.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
| chr7_-_150497621 | 18.96 |
ENST00000434545.1
|
TMEM176B
|
transmembrane protein 176B |
| chr19_-_10445399 | 18.62 |
ENST00000592945.1
|
ICAM3
|
intercellular adhesion molecule 3 |
| chr12_+_7055631 | 18.58 |
ENST00000543115.1
ENST00000399448.1 |
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6 |
| chrX_-_107019181 | 18.49 |
ENST00000315660.4
ENST00000372384.2 ENST00000502650.1 ENST00000506724.1 |
TSC22D3
|
TSC22 domain family, member 3 |
| chr7_+_150497569 | 18.01 |
ENST00000004103.3
|
TMEM176A
|
transmembrane protein 176A |
| chr22_+_37257015 | 17.15 |
ENST00000447071.1
ENST00000248899.6 ENST00000397147.4 |
NCF4
|
neutrophil cytosolic factor 4, 40kDa |
| chr16_+_33605231 | 17.10 |
ENST00000570121.2
|
IGHV3OR16-12
|
immunoglobulin heavy variable 3/OR16-12 (non-functional) |
| chr17_-_62097927 | 16.79 |
ENST00000578313.1
ENST00000584084.1 ENST00000579788.1 ENST00000579687.1 ENST00000578379.1 ENST00000578892.1 ENST00000412356.1 ENST00000418105.1 |
ICAM2
|
intercellular adhesion molecule 2 |
| chr2_+_61108771 | 16.77 |
ENST00000394479.3
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog |
| chr14_-_106866934 | 16.68 |
ENST00000390618.2
|
IGHV3-38
|
immunoglobulin heavy variable 3-38 (non-functional) |
| chr19_-_2042065 | 15.97 |
ENST00000591588.1
ENST00000591142.1 |
MKNK2
|
MAP kinase interacting serine/threonine kinase 2 |
| chr2_-_43453734 | 14.93 |
ENST00000282388.3
|
ZFP36L2
|
ZFP36 ring finger protein-like 2 |
| chr2_+_61108650 | 14.90 |
ENST00000295025.8
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog |
| chr6_+_138188551 | 14.81 |
ENST00000237289.4
ENST00000433680.1 |
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3 |
| chr6_+_31554826 | 14.76 |
ENST00000376089.2
ENST00000396112.2 |
LST1
|
leukocyte specific transcript 1 |
| chr6_+_31554779 | 14.05 |
ENST00000376090.2
|
LST1
|
leukocyte specific transcript 1 |
| chr22_-_37640456 | 14.02 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
| chr17_-_62097904 | 13.37 |
ENST00000583366.1
|
ICAM2
|
intercellular adhesion molecule 2 |
| chr2_+_10183651 | 13.33 |
ENST00000305883.1
|
KLF11
|
Kruppel-like factor 11 |
| chr14_-_106573756 | 13.00 |
ENST00000390601.2
|
IGHV3-11
|
immunoglobulin heavy variable 3-11 (gene/pseudogene) |
| chr7_+_150497491 | 12.96 |
ENST00000484928.1
|
TMEM176A
|
transmembrane protein 176A |
| chr6_-_31704282 | 12.31 |
ENST00000375784.3
ENST00000375779.2 |
CLIC1
|
chloride intracellular channel 1 |
| chr7_+_30960915 | 11.79 |
ENST00000441328.2
ENST00000409899.1 ENST00000409611.1 |
AQP1
|
aquaporin 1 (Colton blood group) |
| chr2_+_89999259 | 11.77 |
ENST00000558026.1
|
IGKV2D-28
|
immunoglobulin kappa variable 2D-28 |
| chr14_-_106926724 | 11.60 |
ENST00000434710.1
|
IGHV3-43
|
immunoglobulin heavy variable 3-43 |
| chr11_-_64510409 | 11.39 |
ENST00000394429.1
ENST00000394428.1 |
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
| chr16_+_56970567 | 10.94 |
ENST00000563911.1
|
HERPUD1
|
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
| chr17_-_62084241 | 10.93 |
ENST00000449662.2
|
ICAM2
|
intercellular adhesion molecule 2 |
| chr1_+_212738676 | 10.54 |
ENST00000366981.4
ENST00000366987.2 |
ATF3
|
activating transcription factor 3 |
| chr5_-_39219705 | 10.12 |
ENST00000351578.6
|
FYB
|
FYN binding protein |
| chr3_-_58196939 | 9.87 |
ENST00000394549.2
ENST00000461914.3 |
DNASE1L3
|
deoxyribonuclease I-like 3 |
| chr17_-_34207295 | 9.81 |
ENST00000463941.1
ENST00000293272.3 |
CCL5
|
chemokine (C-C motif) ligand 5 |
| chr14_-_106845789 | 9.27 |
ENST00000390617.2
|
IGHV3-35
|
immunoglobulin heavy variable 3-35 (non-functional) |
| chr14_-_106518922 | 9.27 |
ENST00000390598.2
|
IGHV3-7
|
immunoglobulin heavy variable 3-7 |
| chr12_-_14721283 | 9.20 |
ENST00000240617.5
|
PLBD1
|
phospholipase B domain containing 1 |
| chr16_+_32077386 | 9.19 |
ENST00000354689.6
|
IGHV3OR16-9
|
immunoglobulin heavy variable 3/OR16-9 (non-functional) |
| chr1_-_236030216 | 8.96 |
ENST00000389794.3
ENST00000389793.2 |
LYST
|
lysosomal trafficking regulator |
| chr14_-_106725723 | 8.62 |
ENST00000390609.2
|
IGHV3-23
|
immunoglobulin heavy variable 3-23 |
| chr15_+_85923856 | 8.51 |
ENST00000560302.1
ENST00000394518.2 ENST00000361243.2 ENST00000560256.1 |
AKAP13
|
A kinase (PRKA) anchor protein 13 |
| chr11_-_5271122 | 8.51 |
ENST00000330597.3
|
HBG1
|
hemoglobin, gamma A |
| chr5_-_150460914 | 8.50 |
ENST00000389378.2
|
TNIP1
|
TNFAIP3 interacting protein 1 |
| chr14_-_107114267 | 8.46 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
| chr11_-_67276100 | 8.41 |
ENST00000301488.3
|
CDK2AP2
|
cyclin-dependent kinase 2 associated protein 2 |
| chr14_+_75988851 | 8.39 |
ENST00000555504.1
|
BATF
|
basic leucine zipper transcription factor, ATF-like |
| chr3_-_58196688 | 8.34 |
ENST00000486455.1
|
DNASE1L3
|
deoxyribonuclease I-like 3 |
| chr2_+_97481974 | 7.68 |
ENST00000377060.3
ENST00000305510.3 |
CNNM3
|
cyclin M3 |
| chr2_-_157189180 | 7.67 |
ENST00000539077.1
ENST00000424077.1 ENST00000426264.1 ENST00000339562.4 ENST00000421709.1 |
NR4A2
|
nuclear receptor subfamily 4, group A, member 2 |
| chr3_-_49142178 | 7.59 |
ENST00000452739.1
ENST00000414533.1 ENST00000417025.1 |
QARS
|
glutaminyl-tRNA synthetase |
| chr11_+_121447469 | 7.58 |
ENST00000532694.1
ENST00000534286.1 |
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
| chr8_-_101321584 | 7.57 |
ENST00000523167.1
|
RNF19A
|
ring finger protein 19A, RBR E3 ubiquitin protein ligase |
| chr6_+_31554456 | 7.40 |
ENST00000339530.4
|
LST1
|
leukocyte specific transcript 1 |
| chr16_+_33020496 | 7.39 |
ENST00000565407.2
|
IGHV3OR16-8
|
immunoglobulin heavy variable 3/OR16-8 (non-functional) |
| chr4_+_155484155 | 7.31 |
ENST00000509493.1
|
FGB
|
fibrinogen beta chain |
| chr5_+_40679584 | 7.08 |
ENST00000302472.3
|
PTGER4
|
prostaglandin E receptor 4 (subtype EP4) |
| chr15_+_74908147 | 6.98 |
ENST00000568139.1
ENST00000563297.1 ENST00000568488.1 ENST00000352989.5 ENST00000348245.3 |
CLK3
|
CDC-like kinase 3 |
| chr13_-_46964177 | 6.90 |
ENST00000389908.3
|
KIAA0226L
|
KIAA0226-like |
| chr14_+_103589789 | 6.85 |
ENST00000558056.1
ENST00000560869.1 |
TNFAIP2
|
tumor necrosis factor, alpha-induced protein 2 |
| chr5_-_150460539 | 6.81 |
ENST00000520931.1
ENST00000520695.1 ENST00000521591.1 ENST00000518977.1 |
TNIP1
|
TNFAIP3 interacting protein 1 |
| chr5_-_39219641 | 6.73 |
ENST00000509072.1
ENST00000504542.1 ENST00000505428.1 ENST00000506557.1 |
FYB
|
FYN binding protein |
| chr17_-_39093672 | 6.63 |
ENST00000209718.3
ENST00000436344.3 ENST00000485751.1 |
KRT23
|
keratin 23 (histone deacetylase inducible) |
| chr7_+_30951461 | 6.59 |
ENST00000311813.4
|
AQP1
|
aquaporin 1 (Colton blood group) |
| chr12_+_112451120 | 6.40 |
ENST00000261735.3
ENST00000455836.1 |
ERP29
|
endoplasmic reticulum protein 29 |
| chr7_-_99097863 | 6.35 |
ENST00000426306.2
ENST00000337673.6 |
ZNF394
|
zinc finger protein 394 |
| chr19_-_40336969 | 6.26 |
ENST00000599134.1
ENST00000597634.1 ENST00000598417.1 ENST00000601274.1 ENST00000594309.1 ENST00000221801.3 |
FBL
|
fibrillarin |
| chr1_-_202129105 | 6.19 |
ENST00000367279.4
|
PTPN7
|
protein tyrosine phosphatase, non-receptor type 7 |
| chr8_+_27168988 | 6.17 |
ENST00000397501.1
ENST00000338238.4 ENST00000544172.1 |
PTK2B
|
protein tyrosine kinase 2 beta |
| chr1_-_40041925 | 6.14 |
ENST00000372862.3
|
PABPC4
|
poly(A) binding protein, cytoplasmic 4 (inducible form) |
| chr7_+_107110488 | 6.13 |
ENST00000304402.4
|
GPR22
|
G protein-coupled receptor 22 |
| chr6_-_112115074 | 6.12 |
ENST00000368667.2
|
FYN
|
FYN oncogene related to SRC, FGR, YES |
| chr17_+_7461781 | 6.11 |
ENST00000349228.4
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13 |
| chr12_+_10658201 | 6.08 |
ENST00000322446.3
|
EIF2S3L
|
Putative eukaryotic translation initiation factor 2 subunit 3-like protein |
| chr1_+_111770278 | 6.06 |
ENST00000369748.4
|
CHI3L2
|
chitinase 3-like 2 |
| chr1_-_40042073 | 6.04 |
ENST00000372858.3
|
PABPC4
|
poly(A) binding protein, cytoplasmic 4 (inducible form) |
| chr10_+_114133773 | 5.99 |
ENST00000354655.4
|
ACSL5
|
acyl-CoA synthetase long-chain family member 5 |
| chr4_+_155484103 | 5.85 |
ENST00000302068.4
|
FGB
|
fibrinogen beta chain |
| chr17_+_43209967 | 5.82 |
ENST00000431281.1
ENST00000591859.1 |
ACBD4
|
acyl-CoA binding domain containing 4 |
| chr1_-_159893507 | 5.81 |
ENST00000368096.1
|
TAGLN2
|
transgelin 2 |
| chr1_+_111770232 | 5.78 |
ENST00000369744.2
|
CHI3L2
|
chitinase 3-like 2 |
| chr16_-_33647696 | 5.77 |
ENST00000558425.1
ENST00000569103.2 |
RP11-812E19.9
|
Uncharacterized protein |
| chr11_+_65190245 | 5.68 |
ENST00000499732.1
ENST00000501122.2 ENST00000601801.1 |
NEAT1
|
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
| chr1_+_156123359 | 5.68 |
ENST00000368284.1
ENST00000368286.2 ENST00000438830.1 |
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
| chr17_-_40897043 | 5.59 |
ENST00000428826.2
ENST00000592492.1 ENST00000585893.1 ENST00000593214.1 ENST00000590078.1 ENST00000586382.1 ENST00000415827.2 ENST00000592743.1 ENST00000586089.1 ENST00000435174.1 |
EZH1
|
enhancer of zeste homolog 1 (Drosophila) |
| chr3_-_49131013 | 5.55 |
ENST00000424300.1
|
QRICH1
|
glutamine-rich 1 |
| chr1_+_156123318 | 5.54 |
ENST00000368285.3
|
SEMA4A
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
| chr6_+_31554612 | 5.46 |
ENST00000211921.7
|
LST1
|
leukocyte specific transcript 1 |
| chr10_+_129705299 | 5.44 |
ENST00000254667.3
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E |
| chr18_+_21083437 | 5.41 |
ENST00000269221.3
ENST00000590868.1 ENST00000592119.1 |
C18orf8
|
chromosome 18 open reading frame 8 |
| chr22_-_50964849 | 5.24 |
ENST00000543927.1
ENST00000423348.1 |
SCO2
|
SCO2 cytochrome c oxidase assembly protein |
| chr12_-_14133053 | 5.24 |
ENST00000609686.1
|
GRIN2B
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
| chr17_-_46623441 | 5.23 |
ENST00000330070.4
|
HOXB2
|
homeobox B2 |
| chr16_-_11681316 | 5.16 |
ENST00000571688.1
|
LITAF
|
lipopolysaccharide-induced TNF factor |
| chr1_-_47069955 | 5.14 |
ENST00000341183.5
ENST00000496619.1 |
MKNK1
|
MAP kinase interacting serine/threonine kinase 1 |
| chr16_+_33006369 | 5.11 |
ENST00000425181.3
|
IGHV3OR16-10
|
immunoglobulin heavy variable 3/OR16-10 (non-functional) |
| chr3_+_9773409 | 5.08 |
ENST00000433861.2
ENST00000424362.1 ENST00000383829.2 ENST00000302054.3 ENST00000420291.1 |
BRPF1
|
bromodomain and PHD finger containing, 1 |
| chr13_+_30002846 | 5.05 |
ENST00000542829.1
|
MTUS2
|
microtubule associated tumor suppressor candidate 2 |
| chr1_-_200379129 | 5.04 |
ENST00000367353.1
|
ZNF281
|
zinc finger protein 281 |
| chr13_+_28712614 | 5.04 |
ENST00000380958.3
|
PAN3
|
PAN3 poly(A) specific ribonuclease subunit homolog (S. cerevisiae) |
| chr11_-_3862206 | 4.97 |
ENST00000351018.4
|
RHOG
|
ras homolog family member G |
| chr16_+_32063311 | 4.93 |
ENST00000426099.1
|
AC142381.1
|
AC142381.1 |
| chr12_-_113909877 | 4.92 |
ENST00000261731.3
|
LHX5
|
LIM homeobox 5 |
| chr14_-_106586656 | 4.84 |
ENST00000390602.2
|
IGHV3-13
|
immunoglobulin heavy variable 3-13 |
| chr19_-_55770311 | 4.83 |
ENST00000412770.2
|
PPP6R1
|
protein phosphatase 6, regulatory subunit 1 |
| chr22_-_29949680 | 4.82 |
ENST00000397873.2
ENST00000490103.1 |
THOC5
|
THO complex 5 |
| chr10_-_125851961 | 4.75 |
ENST00000346248.5
|
CHST15
|
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
| chr15_+_91427642 | 4.74 |
ENST00000328850.3
ENST00000414248.2 |
FES
|
feline sarcoma oncogene |
| chrX_-_73072534 | 4.71 |
ENST00000429829.1
|
XIST
|
X inactive specific transcript (non-protein coding) |
| chr16_-_20556492 | 4.71 |
ENST00000568098.1
|
ACSM2B
|
acyl-CoA synthetase medium-chain family member 2B |
| chr12_+_52445191 | 4.69 |
ENST00000243050.1
ENST00000394825.1 ENST00000550763.1 ENST00000394824.2 ENST00000548232.1 ENST00000562373.1 |
NR4A1
|
nuclear receptor subfamily 4, group A, member 1 |
| chr9_-_116837249 | 4.67 |
ENST00000466610.2
|
AMBP
|
alpha-1-microglobulin/bikunin precursor |
| chr6_+_31554636 | 4.67 |
ENST00000433492.1
|
LST1
|
leukocyte specific transcript 1 |
| chr5_+_49962495 | 4.62 |
ENST00000515175.1
|
PARP8
|
poly (ADP-ribose) polymerase family, member 8 |
| chr1_+_46640750 | 4.61 |
ENST00000372003.1
|
TSPAN1
|
tetraspanin 1 |
| chr17_-_26876350 | 4.53 |
ENST00000470125.1
|
UNC119
|
unc-119 homolog (C. elegans) |
| chr19_-_5978090 | 4.52 |
ENST00000592621.1
ENST00000034275.8 ENST00000591092.1 ENST00000591333.1 ENST00000590623.1 ENST00000439268.2 ENST00000587159.1 |
RANBP3
|
RAN binding protein 3 |
| chr4_-_109087872 | 4.48 |
ENST00000510624.1
|
LEF1
|
lymphoid enhancer-binding factor 1 |
| chr11_+_116700614 | 4.41 |
ENST00000375345.1
|
APOC3
|
apolipoprotein C-III |
| chr17_-_48943706 | 4.32 |
ENST00000499247.2
|
TOB1
|
transducer of ERBB2, 1 |
| chr3_-_101232019 | 4.30 |
ENST00000394095.2
ENST00000394091.1 ENST00000394094.2 ENST00000358203.3 ENST00000348610.3 ENST00000314261.7 |
SENP7
|
SUMO1/sentrin specific peptidase 7 |
| chr7_+_73442102 | 4.27 |
ENST00000445912.1
ENST00000252034.7 |
ELN
|
elastin |
| chr1_+_221051699 | 4.26 |
ENST00000366903.6
|
HLX
|
H2.0-like homeobox |
| chr6_-_27440460 | 4.24 |
ENST00000377419.1
|
ZNF184
|
zinc finger protein 184 |
| chr14_-_106622419 | 4.22 |
ENST00000390604.2
|
IGHV3-16
|
immunoglobulin heavy variable 3-16 (non-functional) |
| chr9_-_123691047 | 4.21 |
ENST00000373887.3
|
TRAF1
|
TNF receptor-associated factor 1 |
| chr16_+_72088376 | 4.20 |
ENST00000570083.1
ENST00000355906.5 ENST00000398131.2 ENST00000569639.1 ENST00000564499.1 ENST00000357763.4 ENST00000562526.1 ENST00000565574.1 ENST00000568417.2 ENST00000356967.5 |
HP
HPR
|
haptoglobin haptoglobin-related protein |
| chr1_+_37940153 | 4.17 |
ENST00000373087.6
|
ZC3H12A
|
zinc finger CCCH-type containing 12A |
| chr1_-_47069886 | 4.10 |
ENST00000371946.4
ENST00000371945.4 ENST00000428112.2 ENST00000529170.1 |
MKNK1
|
MAP kinase interacting serine/threonine kinase 1 |
| chr11_+_116700600 | 4.09 |
ENST00000227667.3
|
APOC3
|
apolipoprotein C-III |
| chr12_-_113772835 | 4.07 |
ENST00000552014.1
ENST00000548186.1 ENST00000202831.3 ENST00000549181.1 |
SLC8B1
|
solute carrier family 8 (sodium/lithium/calcium exchanger), member B1 |
| chr10_+_20105157 | 4.05 |
ENST00000377242.3
ENST00000377252.4 |
PLXDC2
|
plexin domain containing 2 |
| chr12_-_57504069 | 4.04 |
ENST00000543873.2
ENST00000554663.1 ENST00000557635.1 |
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced |
| chr15_+_45003675 | 4.04 |
ENST00000558401.1
ENST00000559916.1 ENST00000544417.1 |
B2M
|
beta-2-microglobulin |
| chr21_+_34775698 | 4.00 |
ENST00000381995.1
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1) |
| chr17_+_37793318 | 3.87 |
ENST00000336308.5
|
STARD3
|
StAR-related lipid transfer (START) domain containing 3 |
| chr15_+_91427691 | 3.78 |
ENST00000559355.1
ENST00000394302.1 |
FES
|
feline sarcoma oncogene |
| chr2_-_100721178 | 3.77 |
ENST00000409236.2
|
AFF3
|
AF4/FMR2 family, member 3 |
| chr5_+_142149955 | 3.75 |
ENST00000378004.3
|
ARHGAP26
|
Rho GTPase activating protein 26 |
| chr2_-_88427568 | 3.73 |
ENST00000393750.3
ENST00000295834.3 |
FABP1
|
fatty acid binding protein 1, liver |
| chr7_+_73442422 | 3.72 |
ENST00000358929.4
ENST00000431562.1 ENST00000320492.7 ENST00000438906.1 |
ELN
|
elastin |
| chr11_+_75526212 | 3.70 |
ENST00000356136.3
|
UVRAG
|
UV radiation resistance associated |
| chr1_+_221054584 | 3.70 |
ENST00000549319.1
|
HLX
|
H2.0-like homeobox |
| chr1_+_54359854 | 3.65 |
ENST00000361921.3
ENST00000322679.6 ENST00000532493.1 ENST00000525202.1 ENST00000524406.1 ENST00000388876.3 |
DIO1
|
deiodinase, iodothyronine, type I |
| chr9_+_82187487 | 3.64 |
ENST00000435650.1
ENST00000414465.1 ENST00000376537.4 ENST00000376534.4 |
TLE4
|
transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) |
| chr15_-_77712477 | 3.60 |
ENST00000560626.2
|
PEAK1
|
pseudopodium-enriched atypical kinase 1 |
| chr17_+_37793378 | 3.58 |
ENST00000544210.2
ENST00000581894.1 ENST00000394250.4 ENST00000579479.1 ENST00000577248.1 ENST00000580611.1 |
STARD3
|
StAR-related lipid transfer (START) domain containing 3 |
| chr11_+_71846748 | 3.58 |
ENST00000445078.2
|
FOLR3
|
folate receptor 3 (gamma) |
| chr10_+_81838792 | 3.57 |
ENST00000372273.3
|
TMEM254
|
transmembrane protein 254 |
| chr4_-_109087906 | 3.56 |
ENST00000515500.1
|
LEF1
|
lymphoid enhancer-binding factor 1 |
| chr1_+_114522049 | 3.55 |
ENST00000369551.1
ENST00000320334.4 |
OLFML3
|
olfactomedin-like 3 |
| chr3_+_52821841 | 3.54 |
ENST00000405128.3
|
ITIH1
|
inter-alpha-trypsin inhibitor heavy chain 1 |
| chr7_-_8301768 | 3.52 |
ENST00000265577.7
|
ICA1
|
islet cell autoantigen 1, 69kDa |
| chr6_+_33176265 | 3.48 |
ENST00000374656.4
|
RING1
|
ring finger protein 1 |
| chr19_-_51522955 | 3.47 |
ENST00000358789.3
|
KLK10
|
kallikrein-related peptidase 10 |
| chr1_-_200379180 | 3.44 |
ENST00000294740.3
|
ZNF281
|
zinc finger protein 281 |
| chr11_-_46142615 | 3.43 |
ENST00000529734.1
ENST00000323180.6 |
PHF21A
|
PHD finger protein 21A |
| chr17_+_21191341 | 3.39 |
ENST00000526076.2
ENST00000361818.5 ENST00000316920.6 |
MAP2K3
|
mitogen-activated protein kinase kinase 3 |
| chr1_-_6259641 | 3.38 |
ENST00000234875.4
|
RPL22
|
ribosomal protein L22 |
| chr9_+_82187630 | 3.37 |
ENST00000265284.6
|
TLE4
|
transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) |
| chr15_-_55700216 | 3.34 |
ENST00000569205.1
|
CCPG1
|
cell cycle progression 1 |
| chr19_+_17326191 | 3.33 |
ENST00000595101.1
ENST00000596136.1 ENST00000379776.4 |
USE1
|
unconventional SNARE in the ER 1 homolog (S. cerevisiae) |
| chr7_-_8302207 | 3.24 |
ENST00000407906.1
|
ICA1
|
islet cell autoantigen 1, 69kDa |
| chr6_-_35656685 | 3.23 |
ENST00000539068.1
ENST00000540787.1 |
FKBP5
|
FK506 binding protein 5 |
| chr3_+_186383741 | 3.20 |
ENST00000232003.4
|
HRG
|
histidine-rich glycoprotein |
| chr7_+_73442457 | 3.18 |
ENST00000438880.1
ENST00000414324.1 ENST00000380562.4 |
ELN
|
elastin |
| chr15_+_91411810 | 3.12 |
ENST00000268171.3
|
FURIN
|
furin (paired basic amino acid cleaving enzyme) |
| chr21_+_34775772 | 3.12 |
ENST00000405436.1
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1) |
| chr11_+_71846764 | 3.11 |
ENST00000456237.1
ENST00000442948.2 ENST00000546166.1 |
FOLR3
|
folate receptor 3 (gamma) |
| chr7_+_73442487 | 3.11 |
ENST00000380575.4
ENST00000380584.4 ENST00000458204.1 ENST00000357036.5 ENST00000417091.1 ENST00000429192.1 ENST00000442310.1 ENST00000380553.4 ENST00000380576.5 ENST00000428787.1 ENST00000320399.6 |
ELN
|
elastin |
| chr9_+_82188077 | 3.08 |
ENST00000425506.1
|
TLE4
|
transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) |
| chr6_-_43484718 | 3.04 |
ENST00000372422.2
|
YIPF3
|
Yip1 domain family, member 3 |
| chr1_-_169599314 | 3.04 |
ENST00000367786.2
ENST00000458599.2 ENST00000367795.2 ENST00000263686.6 |
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62) |
| chr1_-_160231451 | 3.04 |
ENST00000495887.1
|
DCAF8
|
DDB1 and CUL4 associated factor 8 |
| chr7_-_8301682 | 3.00 |
ENST00000396675.3
ENST00000430867.1 |
ICA1
|
islet cell autoantigen 1, 69kDa |
| chr11_-_119999611 | 2.98 |
ENST00000529044.1
|
TRIM29
|
tripartite motif containing 29 |
| chr11_+_118754475 | 2.98 |
ENST00000292174.4
|
CXCR5
|
chemokine (C-X-C motif) receptor 5 |
| chrX_+_149737046 | 2.96 |
ENST00000370396.2
ENST00000542741.1 ENST00000543350.1 ENST00000424519.1 ENST00000413012.2 |
MTM1
|
myotubularin 1 |
| chr11_-_119999539 | 2.91 |
ENST00000541857.1
|
TRIM29
|
tripartite motif containing 29 |
| chr19_-_52133588 | 2.86 |
ENST00000570106.2
|
SIGLEC5
|
sialic acid binding Ig-like lectin 5 |
| chr11_+_58910201 | 2.85 |
ENST00000528737.1
|
FAM111A
|
family with sequence similarity 111, member A |
Network of associatons between targets according to the STRING database.
First level regulatory network of HIVEP1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 12.5 | 50.0 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
| 11.8 | 117.8 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 6.5 | 38.7 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 6.2 | 24.7 | GO:0000255 | allantoin metabolic process(GO:0000255) |
| 6.1 | 18.4 | GO:0072229 | carbon dioxide transmembrane transport(GO:0035378) proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
| 5.5 | 71.6 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 5.1 | 15.3 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 4.9 | 24.6 | GO:0002906 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 4.6 | 18.6 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
| 3.5 | 10.5 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 3.1 | 34.4 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 3.0 | 9.0 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 2.8 | 8.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 2.8 | 8.5 | GO:2000910 | regulation of cholesterol import(GO:0060620) negative regulation of cholesterol import(GO:0060621) regulation of sterol import(GO:2000909) negative regulation of sterol import(GO:2000910) |
| 2.7 | 19.1 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 2.7 | 34.5 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 2.6 | 7.7 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 2.5 | 7.6 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 2.5 | 7.6 | GO:1902771 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
| 2.5 | 9.8 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 2.4 | 7.1 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 2.3 | 18.5 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 1.8 | 14.3 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
| 1.8 | 125.0 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 1.7 | 5.2 | GO:0021569 | rhombomere 3 development(GO:0021569) |
| 1.7 | 8.4 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 1.6 | 8.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
| 1.6 | 3.2 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 1.6 | 6.4 | GO:0043335 | protein unfolding(GO:0043335) |
| 1.6 | 6.3 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 1.5 | 6.2 | GO:2000537 | regulation of cGMP-mediated signaling(GO:0010752) regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
| 1.4 | 4.2 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 1.3 | 4.0 | GO:0002296 | T-helper 1 cell lineage commitment(GO:0002296) |
| 1.3 | 8.0 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
| 1.3 | 13.2 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 1.2 | 3.7 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 1.2 | 2.3 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
| 1.1 | 4.5 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 1.1 | 10.9 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 1.1 | 11.8 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 1.1 | 18.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 1.1 | 19.1 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 1.0 | 3.1 | GO:0032900 | negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) negative regulation of neurotrophin production(GO:0032900) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 1.0 | 91.1 | GO:0050672 | negative regulation of mononuclear cell proliferation(GO:0032945) negative regulation of lymphocyte proliferation(GO:0050672) |
| 1.0 | 4.9 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 1.0 | 1.9 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 1.0 | 116.2 | GO:0031295 | T cell costimulation(GO:0031295) |
| 1.0 | 7.7 | GO:0046898 | response to cycloheximide(GO:0046898) |
| 0.9 | 3.6 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
| 0.9 | 11.2 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
| 0.8 | 7.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.8 | 8.9 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.8 | 5.6 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.8 | 3.2 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.8 | 2.4 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.7 | 3.0 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.7 | 1.4 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
| 0.7 | 13.2 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
| 0.7 | 2.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.7 | 4.7 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.7 | 3.3 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.7 | 5.9 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
| 0.6 | 4.5 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.6 | 1.9 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.6 | 6.9 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.6 | 1.8 | GO:1903347 | negative regulation of bicellular tight junction assembly(GO:1903347) |
| 0.6 | 60.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.6 | 3.6 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
| 0.6 | 2.3 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.6 | 5.2 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.6 | 8.5 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.6 | 1.7 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
| 0.6 | 9.5 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
| 0.6 | 17.1 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.5 | 9.2 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.5 | 4.1 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
| 0.5 | 8.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.5 | 2.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 0.4 | 1.3 | GO:0052314 | serotonin biosynthetic process(GO:0042427) phytoalexin metabolic process(GO:0052314) |
| 0.4 | 6.7 | GO:0015884 | folic acid transport(GO:0015884) |
| 0.4 | 1.3 | GO:0045229 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.4 | 4.4 | GO:0098914 | membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.4 | 3.4 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.4 | 1.2 | GO:0035754 | B cell chemotaxis(GO:0035754) |
| 0.4 | 2.0 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.4 | 7.5 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.4 | 1.9 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 0.4 | 3.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.4 | 3.7 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.3 | 15.7 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.3 | 2.5 | GO:1903142 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.3 | 4.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.3 | 4.3 | GO:1902373 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) negative regulation of mRNA catabolic process(GO:1902373) |
| 0.3 | 5.2 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.3 | 46.5 | GO:0002223 | stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.3 | 0.9 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) cellular alkene metabolic process(GO:0043449) |
| 0.3 | 1.0 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
| 0.2 | 1.7 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.2 | 0.7 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.2 | 28.4 | GO:0002377 | immunoglobulin production(GO:0002377) |
| 0.2 | 1.9 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.2 | 3.5 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.2 | 1.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.2 | 7.8 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.2 | 10.1 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
| 0.2 | 7.1 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.2 | 1.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.2 | 5.2 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.2 | 2.0 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 0.2 | 5.0 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.2 | 0.3 | GO:0002468 | dendritic cell antigen processing and presentation(GO:0002468) regulation of dendritic cell antigen processing and presentation(GO:0002604) positive regulation of dendritic cell antigen processing and presentation(GO:0002606) |
| 0.2 | 1.5 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.2 | 1.2 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 0.2 | 2.7 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.2 | 2.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.1 | 1.2 | GO:0051262 | protein tetramerization(GO:0051262) |
| 0.1 | 0.4 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.1 | 0.9 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 0.1 | 1.5 | GO:0060013 | righting reflex(GO:0060013) |
| 0.1 | 1.4 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
| 0.1 | 3.0 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 0.1 | 0.7 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.1 | 0.8 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) |
| 0.1 | 10.2 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.1 | 3.5 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.1 | 5.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 | 4.8 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
| 0.1 | 2.0 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 0.1 | 1.2 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.1 | 2.1 | GO:0044705 | mating behavior(GO:0007617) multi-organism reproductive behavior(GO:0044705) |
| 0.1 | 2.1 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
| 0.1 | 1.6 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.1 | 2.8 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 0.1 | 2.5 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
| 0.1 | 2.5 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
| 0.1 | 10.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.1 | 1.7 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
| 0.1 | 0.7 | GO:0032328 | alanine transport(GO:0032328) |
| 0.1 | 2.5 | GO:0070734 | histone H3-K27 methylation(GO:0070734) |
| 0.1 | 2.1 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.1 | 1.6 | GO:0019098 | reproductive behavior(GO:0019098) maternal behavior(GO:0042711) parental behavior(GO:0060746) |
| 0.1 | 5.4 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
| 0.1 | 3.2 | GO:1903393 | positive regulation of focal adhesion assembly(GO:0051894) positive regulation of adherens junction organization(GO:1903393) |
| 0.1 | 0.2 | GO:0060437 | lung growth(GO:0060437) |
| 0.1 | 2.2 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.1 | 1.6 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.1 | 2.6 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
| 0.1 | 2.5 | GO:0035306 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
| 0.1 | 3.0 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.1 | 0.5 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 | 2.2 | GO:0098743 | cell aggregation(GO:0098743) |
| 0.1 | 0.5 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.1 | 3.2 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 | 2.1 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
| 0.1 | 3.7 | GO:0001510 | RNA methylation(GO:0001510) |
| 0.1 | 2.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 | 1.6 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.1 | 1.3 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.1 | 0.4 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.1 | 0.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 | 0.6 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
| 0.1 | 2.4 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.1 | 4.3 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.1 | 2.7 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
| 0.1 | 6.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 | 2.6 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
| 0.1 | 3.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.1 | 2.6 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.1 | 2.8 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.1 | 2.6 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
| 0.1 | 1.0 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.1 | 0.5 | GO:0045124 | regulation of bone resorption(GO:0045124) |
| 0.1 | 1.2 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
| 0.1 | 1.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.1 | 0.6 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
| 0.0 | 6.0 | GO:0001676 | long-chain fatty acid metabolic process(GO:0001676) |
| 0.0 | 0.7 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 0.0 | 0.8 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.0 | 2.2 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
| 0.0 | 2.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
| 0.0 | 3.4 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.0 | 1.3 | GO:0030449 | regulation of complement activation(GO:0030449) |
| 0.0 | 5.3 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.0 | 0.2 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.0 | 0.2 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.0 | 5.0 | GO:0050796 | regulation of insulin secretion(GO:0050796) |
| 0.0 | 2.3 | GO:0016575 | histone deacetylation(GO:0016575) |
| 0.0 | 0.8 | GO:0032570 | response to progesterone(GO:0032570) |
| 0.0 | 1.5 | GO:0007528 | neuromuscular junction development(GO:0007528) |
| 0.0 | 1.9 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
| 0.0 | 1.6 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.0 | 0.2 | GO:0007631 | feeding behavior(GO:0007631) |
| 0.0 | 1.3 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.0 | 0.2 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.0 | 1.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) mitochondrial translational termination(GO:0070126) |
| 0.0 | 1.7 | GO:0002027 | regulation of heart rate(GO:0002027) |
| 0.0 | 0.6 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
| 0.0 | 0.7 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
| 0.0 | 0.9 | GO:0007219 | Notch signaling pathway(GO:0007219) |
| 0.0 | 0.2 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.0 | 1.1 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.0 | 0.3 | GO:0034142 | toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.0 | 1.0 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.0 | 0.1 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.0 | 1.7 | GO:0007162 | negative regulation of cell adhesion(GO:0007162) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 10.7 | 117.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 8.7 | 181.8 | GO:0042611 | MHC protein complex(GO:0042611) |
| 6.1 | 18.4 | GO:0020005 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
| 4.8 | 57.6 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 3.5 | 10.5 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 2.5 | 125.0 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 2.1 | 17.1 | GO:0032010 | phagolysosome(GO:0032010) |
| 2.1 | 6.3 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 1.8 | 10.9 | GO:1990037 | Lewy body core(GO:1990037) |
| 1.8 | 41.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 1.7 | 18.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 1.7 | 5.0 | GO:0031251 | PAN complex(GO:0031251) |
| 1.4 | 14.3 | GO:0071953 | elastic fiber(GO:0071953) |
| 1.1 | 8.5 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 1.1 | 12.6 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
| 1.1 | 4.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 1.0 | 19.1 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.8 | 5.9 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.8 | 11.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.7 | 7.5 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.7 | 8.0 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.7 | 8.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.7 | 4.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.7 | 8.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.7 | 2.0 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.6 | 7.7 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.6 | 4.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.5 | 5.1 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
| 0.5 | 7.6 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.4 | 27.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.4 | 0.7 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.4 | 7.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.4 | 2.5 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.3 | 5.2 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.3 | 3.5 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.3 | 2.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.3 | 2.2 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.3 | 6.9 | GO:0000145 | exocyst(GO:0000145) |
| 0.3 | 1.2 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.3 | 2.4 | GO:0045179 | apical cortex(GO:0045179) |
| 0.3 | 4.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.3 | 2.0 | GO:0060091 | kinocilium(GO:0060091) |
| 0.3 | 3.7 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.3 | 45.9 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.3 | 16.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.3 | 2.0 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.2 | 1.0 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
| 0.2 | 4.3 | GO:0005861 | troponin complex(GO:0005861) |
| 0.2 | 1.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 0.2 | 4.5 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 2.1 | GO:0036038 | MKS complex(GO:0036038) |
| 0.1 | 2.6 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.1 | 11.7 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.1 | 8.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 1.6 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.1 | 2.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.1 | 1.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.1 | 42.8 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.1 | 2.8 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.1 | 3.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.1 | 8.4 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.1 | 0.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.1 | 2.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.1 | 2.5 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.1 | 4.2 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.1 | 20.5 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.1 | 2.3 | GO:0005685 | U1 snRNP(GO:0005685) |
| 0.1 | 8.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.1 | 63.9 | GO:0000139 | Golgi membrane(GO:0000139) |
| 0.1 | 1.9 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.1 | 5.5 | GO:0030175 | filopodium(GO:0030175) |
| 0.1 | 2.7 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.1 | 1.4 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
| 0.1 | 3.8 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.1 | 0.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.1 | 7.7 | GO:0016605 | PML body(GO:0016605) |
| 0.1 | 3.4 | GO:1990391 | DNA repair complex(GO:1990391) |
| 0.1 | 0.7 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.1 | 13.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 3.4 | GO:0015030 | Cajal body(GO:0015030) |
| 0.1 | 2.0 | GO:0016592 | mediator complex(GO:0016592) |
| 0.1 | 1.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.1 | 0.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.0 | 4.7 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.0 | 1.8 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.0 | 2.9 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.0 | 3.9 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.0 | 2.8 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 5.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
| 0.0 | 16.8 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 1.5 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 3.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.0 | 0.2 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.0 | 1.2 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.0 | 0.2 | GO:0030133 | transport vesicle(GO:0030133) |
| 0.0 | 4.3 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
| 0.0 | 0.7 | GO:0034358 | plasma lipoprotein particle(GO:0034358) lipoprotein particle(GO:1990777) |
| 0.0 | 7.9 | GO:0005813 | centrosome(GO:0005813) |
| 0.0 | 7.3 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
| 0.0 | 2.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 1.2 | GO:0005923 | bicellular tight junction(GO:0005923) |
| 0.0 | 1.3 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.0 | 0.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 9.7 | 136.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 8.0 | 47.8 | GO:0046979 | TAP2 binding(GO:0046979) |
| 6.1 | 24.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 6.1 | 18.4 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
| 4.1 | 12.2 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 2.7 | 65.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 2.5 | 7.6 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 2.4 | 133.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 2.1 | 8.5 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 2.1 | 6.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 2.1 | 18.5 | GO:0043426 | MRF binding(GO:0043426) |
| 1.7 | 5.2 | GO:0042806 | fucose binding(GO:0042806) |
| 1.7 | 17.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 1.5 | 14.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 1.4 | 7.1 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 1.4 | 9.8 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
| 1.4 | 25.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 1.2 | 3.7 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
| 1.2 | 19.1 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
| 1.2 | 4.7 | GO:0019862 | IgA binding(GO:0019862) |
| 1.1 | 11.8 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
| 1.0 | 6.1 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 1.0 | 5.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 1.0 | 1.0 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.9 | 24.0 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.9 | 7.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.9 | 5.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.8 | 21.0 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
| 0.8 | 4.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.8 | 8.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.7 | 3.7 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.7 | 4.4 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.7 | 8.5 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.7 | 7.7 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.7 | 4.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.7 | 2.0 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.7 | 33.7 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.7 | 11.2 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.6 | 11.4 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.6 | 23.4 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.6 | 3.6 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.5 | 3.7 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
| 0.5 | 62.6 | GO:0003823 | antigen binding(GO:0003823) |
| 0.5 | 4.7 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.5 | 1.9 | GO:0038181 | bile acid receptor activity(GO:0038181) |
| 0.5 | 5.2 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.5 | 7.6 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.5 | 8.0 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 0.5 | 2.3 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
| 0.5 | 4.6 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.5 | 1.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.4 | 6.3 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.4 | 11.4 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.4 | 4.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.4 | 15.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.4 | 6.7 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.4 | 7.5 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.3 | 1.7 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.3 | 6.0 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
| 0.3 | 18.4 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
| 0.3 | 2.3 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.3 | 5.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.3 | 7.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.3 | 2.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.3 | 1.8 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.3 | 3.5 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
| 0.3 | 1.4 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.3 | 1.7 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
| 0.3 | 7.5 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.3 | 3.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.3 | 1.6 | GO:0016416 | O-palmitoyltransferase activity(GO:0016416) |
| 0.3 | 2.5 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.2 | 5.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
| 0.2 | 10.9 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.2 | 3.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.2 | 1.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.2 | 4.0 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.2 | 2.6 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.2 | 2.9 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.2 | 0.7 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 0.2 | 0.9 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.2 | 2.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.2 | 3.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.2 | 1.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.2 | 29.2 | GO:0005178 | integrin binding(GO:0005178) |
| 0.2 | 1.3 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.2 | 0.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.2 | 36.7 | GO:0019887 | protein kinase regulator activity(GO:0019887) |
| 0.1 | 3.2 | GO:0019865 | immunoglobulin binding(GO:0019865) |
| 0.1 | 0.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.1 | 4.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.1 | 21.4 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
| 0.1 | 1.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.1 | 3.2 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.1 | 5.8 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.1 | 5.2 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 0.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.1 | 1.9 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.1 | 0.8 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.1 | 2.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 5.9 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.1 | 2.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 0.6 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 3.8 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.1 | 2.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.1 | 4.8 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
| 0.1 | 1.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.1 | 1.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.1 | 5.8 | GO:0046332 | SMAD binding(GO:0046332) |
| 0.1 | 2.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.1 | 4.2 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.1 | 3.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.1 | 20.3 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.1 | 0.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 2.1 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.1 | 3.4 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.1 | 4.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.1 | 4.7 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
| 0.1 | 2.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.1 | 2.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.1 | 4.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.1 | 2.8 | GO:0015026 | coreceptor activity(GO:0015026) |
| 0.1 | 2.2 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 0.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.1 | 1.0 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.1 | 0.7 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.1 | 0.6 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 7.6 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.1 | 1.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.1 | 3.6 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.0 | 0.2 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.0 | 1.5 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
| 0.0 | 1.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.0 | 0.8 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.0 | 19.8 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
| 0.0 | 3.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.0 | 4.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.0 | 2.0 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 0.0 | 1.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.0 | 0.3 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.0 | 1.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.0 | 4.3 | GO:0000149 | SNARE binding(GO:0000149) |
| 0.0 | 7.7 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.0 | 2.8 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.0 | 5.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.0 | 1.5 | GO:0005262 | calcium channel activity(GO:0005262) |
| 0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.0 | 1.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.5 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.0 | 14.1 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.0 | 0.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.0 | 0.5 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.0 | 1.1 | GO:0005179 | hormone activity(GO:0005179) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.9 | 23.6 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 1.5 | 56.6 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 1.4 | 72.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 1.3 | 24.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.8 | 83.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.8 | 38.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.7 | 25.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
| 0.5 | 27.9 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.5 | 6.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.4 | 6.2 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.4 | 3.7 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.2 | 15.5 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.2 | 9.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.2 | 8.5 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 0.2 | 1.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 0.2 | 10.1 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.2 | 2.4 | PID EPO PATHWAY | EPO signaling pathway |
| 0.2 | 2.8 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.2 | 4.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.2 | 9.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
| 0.1 | 8.6 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.1 | 10.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
| 0.1 | 4.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.1 | 3.5 | ST ADRENERGIC | Adrenergic Pathway |
| 0.1 | 10.1 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 19.0 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 1.9 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.1 | 2.1 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 1.7 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.1 | 1.6 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 3.8 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.1 | 2.0 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.1 | 1.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.1 | 0.6 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.0 | 0.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.0 | 3.1 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.0 | 2.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 2.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 1.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
| 0.0 | 0.7 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.0 | 0.7 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.0 | 0.3 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.0 | 0.6 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.0 | 0.5 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 0.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 11.8 | 117.8 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 4.7 | 107.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 2.1 | 18.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 1.7 | 25.7 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 1.5 | 20.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 1.2 | 24.7 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.9 | 45.4 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.8 | 13.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.7 | 23.0 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.7 | 57.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.7 | 21.5 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.6 | 7.1 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.6 | 9.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.6 | 3.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.5 | 8.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.5 | 2.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.5 | 9.2 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.5 | 9.2 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.4 | 8.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.4 | 14.6 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
| 0.4 | 7.1 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.4 | 15.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.3 | 3.1 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.3 | 7.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.3 | 40.0 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
| 0.3 | 28.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.3 | 7.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.3 | 11.4 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.3 | 2.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.2 | 5.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
| 0.2 | 5.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.2 | 3.7 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.2 | 16.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.2 | 8.9 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.2 | 10.1 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.1 | 2.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.1 | 2.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.1 | 1.8 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 3.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.1 | 4.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
| 0.1 | 2.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.1 | 1.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.1 | 2.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 2.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.1 | 13.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.1 | 1.9 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 2.7 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.1 | 0.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.1 | 0.9 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 0.1 | 7.2 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.1 | 1.0 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.1 | 2.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.1 | 1.9 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.1 | 0.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 3.3 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.1 | 2.4 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
| 0.1 | 6.5 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.1 | 1.2 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
| 0.1 | 1.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.1 | 1.8 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 2.1 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.1 | 1.9 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
| 0.0 | 0.8 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.0 | 10.3 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.0 | 0.6 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
| 0.0 | 1.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 0.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.0 | 0.7 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
| 0.0 | 1.4 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
| 0.0 | 0.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.0 | 0.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.0 | 0.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
| 0.0 | 0.7 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |